ALDEYRA
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88494179
- Registration number
- 6154544
- Mark type
- Design + words
- Filed
- 28 Jun 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 15 Sept 2020
- Attorney of record
- Ann Lamport Hammitte
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents for Reactive Aldehyde Species (RASP) inhibition, Dihydrofolate Reductase Inhibition, and by Heat Shock Protein 90 and chaperome Inhibition for the treatment of immune-mediated diseases, dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, Sjögren-Larsson Syndrome, immune-mediated ocular diseases, systemic diseases, proliferative vitreoretinopathy, retinal diseases, post-transplant lymphoproliferative disease, autoimmune disease, metabolic disease, and cancer; pharmaceuticals for use in treatment of immune-mediated diseases; pharmaceuticals for use in treating dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson Syndrome; pharmaceuticals for treating immune-mediated ocular diseases and systemic diseases; pharmaceuticals for treating proliferative vitreoretinopathy, retinal diseases, post-transplant lymphoproliferative disease, autoimmune disease, metabolic disease, and cancer
Owner
- Aldeyra Therapeutics, Inc, Lexington, MA, US
- Aldeyra Therapeutics, Inc, Lexington, MA, US
- Aldeyra Therapeutics, Inc, Lexington, MA, US
Prior registrations
Prosecution history
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jul 2020 — USE AMENDMENT FILED
- 29 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 10 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jul 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Jul 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Apr 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2020 — PUBLISHED FOR OPPOSITION
- 05 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED